Basic Provera Information

• INN (International Nonproprietary Name): Medroxyprogesterone acetate.
• Brand Names Available In Canada (English): Provera and various generics labelled as medroxyprogesterone acetate; injectable forms internationally known as Depo‑Provera and Depo‑SubQ Provera 104.
• ATC Code: G03DA02.
• Forms & Dosages: Oral tablets in 2.5 mg, 5 mg, and 10 mg strengths in bottles of 30, 100, or 500; injectable preparations in 104 mg (Depo‑SubQ) and 150 mg/mL (Depo‑Provera IM) vials or prefilled syringes.
• Manufacturers In Canada (English): Pfizer Inc. is a primary global supplier; additional generics are supplied by regional and international manufacturers under local GMP.
• Registration Status In Canada (English): Products marketed in Canada appear as Provera or generics; check Health Canada Drug Product Database for current DIN listings and product monographs.
• OTC / Rx Classification: Prescription only (Rx) in reviewed markets.

Availability & Price Landscape

Where can patients find provera across Canada and what will it cost?

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Shoppers Drug Mart, Rexall and London Drugs commonly stock Provera tablets and generics in community stores and online listings.

Jean Coutu and some regional chains also carry tablets in many provinces.

Injectable forms such as Depo‑Provera or Depo‑SubQ are often clinic‑administered or available through specialty pharmacy channels rather than retail shelves.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Canadian e‑pharmacies increase access but require a valid prescription and many verify prescriptions against provincial college registries.

Provincial rules affect online dispensing, substitution and pharmacist scope of practice, so availability can differ between Ontario, Quebec, British Columbia and other provinces.

Cross‑border ordering from US sites is common for price savings but risks receiving non‑DIN products or customs seizure, which is why many Canadians prefer in‑country suppliers.

Price Ranges By Package Size (With Provincial Differences)

Expect wide retail price ranges for oral tablets depending on pack size, strength and whether product is branded or generic.

Smaller bottles (30‑count) typically cost more per tablet than larger 100 or 500 packs where per‑tablet cost is lower.

Injectables carry a higher per‑dose price and often include clinic administration fees that vary by province and clinic.

Provincial drug plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ may cover eligible patients for listed indications, so out‑of‑pocket cost depends on coverage and DIN listing.

Canadian Patient Insights & Satisfaction Levels

What are real Canadian users saying online about provera and Depo‑Provera?

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Conversations on Reddit Canada, HealthBoards, provincial Facebook groups and pharmacy review pages often shape patient expectations and purchasing choices.

Threads include product experiences, substitution questions and access discussions tied to provincial programs and pharmacy counselling.

Reported Benefits And Challenges From Canadian Patients

Many users report quick symptom relief for abnormal uterine bleeding when tablets are taken as prescribed.

Depo‑Provera users often value the convenience of three‑month dosing but commonly mention concerns around weight change and menstrual irregularity.

Satisfaction is mixed: some praise predictable endometrial protection in HRT, while others cite mood changes, bloating or prolonged amenorrhea with extended use.

Quebec users frequently discuss access through CLSCs and clinics, whereas BC and Ontario users reference pharmacist counselling at London Drugs and Shoppers for generic substitution and DIN verification.

• Positive: Fast bleeding control for acute cases and convenient contraception dosing.
• Negative: Concerns about mood, weight and long‑term bone density with injectables.

Product Overview & Brand Variants

Which names, strengths and regulated classes should Canadian patients recognise?

INN And Brand Names Used In Canada

The international nonproprietary name is medroxyprogesterone acetate, commonly sold in Canada as Provera or generics labelled by INN.

Tablets are available in 2.5 mg, 5 mg and 10 mg strengths in common retail pack sizes.

Injectable contraceptives are widely known as Depo‑Provera or Depo‑SubQ Provera 104 internationally, and are usually supplied via clinics or specialty channels.

Legal Classification Under Health Canada

Medroxyprogesterone acetate products are prescription‑only and approved products in Canada carry a Health Canada Drug Identification Number (DIN).

Consumers should verify the DIN and manufacturer on packaging and consult the Health Canada Drug Product Database for product monographs.

Indications In Local Canadian Medical Practice

When do Canadian prescribers reach for provera and what dosing is standard?

Approved Uses (Health Canada DIN Context)

Standard approved indications include secondary amenorrhea and abnormal uterine bleeding treated with short oral courses.

Typical tablet regimens use 5 or 10 mg daily for 5–10 days to induce withdrawal bleeding, or 5–10 mg daily for 12–14 days monthly when used with oestrogen in HRT.

Injectable medroxyprogesterone is used for contraception as Depo‑Provera 150 mg IM every three months or Depo‑SubQ 104 mg SQ every three months.

Off‑Label Patterns In Canadian Healthcare

Specialists may prescribe medroxyprogesterone acetate off‑label for endometriosis symptom control, amenorrhea management or specific fertility protocols with documented informed consent.

Primary care and sexual health clinics commonly administer injectables and monitor long‑term users for bone mineral density concerns, following provincial formularies and funding rules.

How It Works In The Body

How does provera act, in plain language and with clinical specifics?

Layman’s Explanation (Canadian Patient‑Friendly Tone)

Provera is a synthetic progestogen that mimics the effect of the hormone progesterone in the body.

It helps stabilise the uterine lining, reduce excessive bleeding and regulate menstrual cycles.

When given as a depot injection, it suppresses ovulation to provide contraception for about three months per dose.

Clinical Detail From Health Canada Resources

Medroxyprogesterone acetate binds progesterone receptors in the endometrium, causing glandular and stromal changes that limit proliferation and allow predictable withdrawal bleeding after short courses.

Depot injections exert systemic suppression of the hypothalamic‑pituitary‑gonadal axis, reducing ovulation.

MPA is metabolised in the liver, so caution is advised in patients with significant hepatic impairment.

Dosage & Administration

What regimens do clinicians follow and how should patients take and store provera?

Standard Regimens Per Canadian Guidelines

Oral tablets: 5 or 10 mg daily for 5–10 days for secondary amenorrhea or abnormal uterine bleeding, often starting around cycle day 16–21.

HRT endometrial protection: 5–10 mg daily for 12–14 consecutive days per month when oestrogen is prescribed.

Injectable contraception: Depo‑Provera IM 150 mg every three months or Depo‑SubQ 104 mg SQ every three months.

Adjustments By Patient Type (With Canadian Clinical Notes)

Children: Not routinely approved; specialist guidance required for any paediatric use.

Elderly: No routine dose change but use caution in patients at increased risk of thromboembolism or dementia.

Liver impairment: Use with caution; medroxyprogesterone acetate is hepatically metabolised and is contraindicated in significant liver dysfunction.

Storage: tablets at or below 25–30°C and injectables at 15–30°C, protected from light and not frozen.

Contraindications & Side Effects

Who should not take provera and what side effects should patients watch for?

Common (Health Canada‑Approved List)

Absolute contraindications include hypersensitivity to medroxyprogesterone acetate, active or prior thromboembolic disease, diagnosed or suspected breast or genital malignancy, undiagnosed vaginal bleeding, significant liver dysfunction and pregnancy until excluded.

Common side effects include menstrual irregularities, weight gain, headache, breast tenderness, bloating, nausea and mood changes.

Injection‑site reactions may occur with depot formulations.

Rare But Serious (With Canadian Pharmacovigilance Data)

Rare but serious events include thromboembolism and hepatic dysfunction.

Long‑term use of depot contraceptives has been associated with reductions in bone mineral density; Canadian clinics commonly reassess treatment duration and monitor bone health after prolonged use.

Screen for cardiovascular risk factors and mental health history before prescribing and document informed consent where appropriate.

Comparable Medicines In Canada

What are the reasonable alternatives to medroxyprogesterone acetate for bleeding control, HRT or contraception?

Alternatives Table (With DIN References)

Alternatives include norethindrone acetate (Aygestin), micronized progesterone (Prometrium), drospirenone‑containing products and levonorgestrel preparations depending on indication.

Choice depends on the treatment goal, tolerability, interactions and provincial formulary listing and coverage.

Pros And Cons List

Medroxyprogesterone acetate pros: effective for short‑term bleeding control and convenient depot contraception with three‑month dosing.

Medroxyprogesterone acetate cons: potential weight and mood changes and bone density concerns with long‑term injectable use.

Micronized progesterone may have a more favourable mood and breast side effect profile for some patients but has different pharmacokinetics and may be less suitable for some contraceptive roles.

Current Research & Trends

What recent studies and trends should Canadian patients and clinicians know about?

Major Canadian Or International Studies 2022–2025

Recent literature focuses on optimizing progestogen selection in HRT and understanding long‑term depot contraceptive effects on bone density and return to fertility after Depo‑Provera.

Meta‑analyses from 2022–2025 compared mood and metabolic outcomes across synthetic progestogens and micronized progesterone.

Small Canadian cohort studies have explored bone density monitoring protocols for long‑term injection users and public health units have measured uptake in community clinics after telemedicine expansion.

Ongoing trials are evaluating alternative depot intervals and dosing strategies to mitigate bone loss while maintaining contraceptive efficacy.

Common Patient Questions In Canada

Short, practical answers to the questions patients ask most.

Is Provera Available Without A Prescription In Canada?

No — provera is prescription‑only in reviewed markets and pharmacies will generally require a valid prescription and DIN‑verified product.

Will Provincial Drug Plans Cover Provera?

Coverage varies by province and by indication; check Ontario Drug Benefit, BC PharmaCare or RAMQ for eligibility and listing.

How Soon Does Provera Stop Bleeding?

Short tablet courses often induce withdrawal bleeding within days to a couple of weeks, but individual response varies.

Can I Buy Depo‑Provera Online From The US?

Cross‑border purchases are possible but risky due to DIN differences and customs; many Canadians prefer domestic suppliers to ensure Health Canada approval.

How Long Should I Use Depo‑Provera?

Reassess after two years of continuous injectable use because of bone mineral density concerns and individual risk factors.

Regulatory Status

How does Health Canada approval work and why is the DIN important?

Health Canada Approval Process

Manufacturers submit safety, efficacy and quality data to Health Canada for review prior to marketing approval.

Post‑market surveillance is maintained and adverse events are reportable to Health Canada and provincial pharmacovigilance systems.

DIN Number Relevance

The Drug Identification Number (DIN) confirms Health Canada approval for a specific manufacturer, formulation and label, and helps patients and pharmacists verify product legitimacy.

Display the product DIN on pharmacy pages and consult the Drug Product Database before purchase or substitution.

Visual Recommendations

What visuals make a product page helpful and trustworthy for Canadian buyers?

Infographic Ideas For Canadian Context

Include a comparison table of forms and strengths (2.5 mg, 5 mg, 10 mg tablets; 104 mg and 150 mg injectables) linked to common uses like acute bleeding, HRT and contraception.

Create a lifecycle infographic showing prescribing, oral versus clinic injection administration, monitoring (bone density, liver tests) and follow‑up intervals.

Add a provincial coverage map highlighting where Ontario Drug Benefit, BC PharmaCare and RAMQ may provide coverage or require special authorisation.

Provide packaging photos with annotated DIN and storage instructions and ensure all visuals include alt text and source citations such as product monographs or Health Canada listings.

Buying & Storage Advice

How should Canadians buy, receive and store provera safely?

In‑Store Vs. Online Canadian Purchase Tips

Purchase from Health Canada‑approved pharmacies with a valid prescription and confirm the DIN and manufacturer on delivery.

In‑store shopping at Shoppers Drug Mart, Rexall, London Drugs or Jean Coutu allows immediate pharmacist counselling and DIN verification.

Online Canadian pharmacies provide convenience but verify certification with provincial college links and expect prescription validation prior to dispensing.

In our online pharmacy, provera is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

Proper Storage With Canadian Climate Considerations

Tablets should be stored at or below 25–30°C and injectables at 15–30°C, protected from light and not frozen.

During cold Canadian winters, avoid leaving medication in a vehicle overnight and use insulated packaging for home deliveries if temperatures are extreme.

Guidelines For Proper Use

What should prescribers and pharmacists document and counsel on in Canada?

Canadian Doctor/Pharmacist Advice Style

Verify indication, document medical history including thromboembolic risk and breast cancer history, and confirm pregnancy status before initiation.

Review concomitant medications for interactions and counsel on expected bleeding patterns and common side effects.

For depot contraception, discuss bone health monitoring and plan to reassess after two years of continuous use.

Provide written dosing instructions, missed‑dose guidance and follow‑up timelines, and ensure DIN verification is recorded when dispensing.

Delivery Across Canada (English)

Final Practical Notes

Check the product DIN and the Health Canada Drug Product Database when verifying brand, strength and manufacturer for any Provera product.

Discuss contraception goals, duration of injectable use and bone health monitoring with a prescriber before starting Depo‑Provera.

When ordering online, confirm prescription validation, DIN verification on receipt and proper temperature‑controlled shipping during extreme weather.

For alternatives or concerns about mood, weight or bleeding patterns, discuss switching options such as norethindrone acetate or micronized progesterone with a clinician, keeping provincial formulary differences in mind.